10-Q: Beyond Meat Reports Steep Losses, Impairment Charges Amid Weak Demand

Beyond Meat reported a significant decline in Q3 2025 net revenues and a substantial increase in net loss, driven by weak category demand and a large impairment charge, while also announcing a major debt exchange and capital raise.

Summary

• Net revenues for the three months ended September 27, 2025, decreased by 13.3% to $70.2 million, down from $81.0 million in the prior-year period.
• Net revenues for the nine months ended September 27, 2025, decreased by 14.4% to $213.9 million, down from $249.8 million in the prior-year period.
• Gross profit for Q3 2025 fell by 49.5% to $7.2 million, with gross margin decreasing to 10.3% from 17.7% year-over-year.
• Net loss for Q3 2025 significantly widened to $110.7 million, compared to a net loss of $26.6 million in Q3 2024.
• A loss from impairment of long-lived assets totaling $77.4 million was recognized in Q3 2025 due to lower-than-expected performance and a sustained decline in stock price.
• The company completed an exchange offer for its 0% Convertible Senior Notes due 2027, exchanging 97.44% of the notes for $209.7 million in 7.00% Convertible Senior Secured Second Lien PIK Toggle Notes due 2030 and 317.8 million shares of common stock.
• Beyond Meat drew the full $100.0 million from its Delayed Draw Term Loan Facility by September 18, 2025, and issued warrants to purchase 9,558,635 shares of common stock at an exercise price of $3.26 per share.
• Subsequent to the quarter, the company sold 58,888,790 shares of common stock under its ATM Program for net proceeds of approximately $148.7 million.
• A material weakness in internal control over financial reporting was identified, related to the accounting for non-recurring and complex transactions, due to inadequate technical resources.

Sentiment

Score: 2

Explanation: The company's financial performance is severely negative, with significant revenue declines, widening losses, and substantial asset impairment. While debt restructuring and capital raises provide some liquidity, they come with heavy dilution and increased debt obligations. The identified material weakness in internal controls and ongoing weak market demand further contribute to a highly unfavorable outlook.

Positives

• Successfully completed a significant debt exchange offer, converting 97.44% of the 2027 Notes into new 2030 Notes and common stock, which helps manage debt maturity.
• Secured $100.0 million through a Delayed Draw Term Loan Facility, providing additional liquidity for general corporate purposes.
• Successfully subleased approximately 54,749 rentable square feet of its Campus Headquarters to Varda Space Industries, Inc., with landlord consent obtained.
• The French High Administrative Court annulled the Contested Decree and New Decree prohibiting meat names for plant-based foods, and Beyond Meat was reimbursed for legal costs.
• An arbitrator found that the company had a valid basis to terminate an agreement with a former co-manufacturer, denying the manufacturer's $73.0 million claim to re-open the hearing.

Negatives

• Net revenues decreased by 13.3% in Q3 2025 and 14.4% in the nine months ended September 27, 2025, primarily due to weak category demand and reduced distribution.
• Gross profit declined by 49.5% in Q3 2025 and 53.4% in the nine months ended September 27, 2025, with gross margin falling to 10.3% and 6.9% respectively.
• Net loss significantly increased to $110.7 million in Q3 2025 and $192.8 million in the nine months ended September 27, 2025, compared to smaller losses in the prior year periods.
• Recognized a substantial $77.4 million impairment loss on long-lived assets due to underperformance and a sustained decline in stock price.
• Identified a material weakness in internal control over financial reporting due to inadequate technical resources for complex transactions.
• Continued workforce reductions (August 2025 RIF of ~40 employees) and suspension of operational activities in China indicate ongoing cost-cutting measures amidst business contraction.
• The company's stock price hit a 52-week low during Q3 2025, reflecting market and trading dynamics unrelated to underlying business performance.
• The exchange offer resulted in substantial dilution to existing stockholders, with 317.8 million new shares issued, and potential for further dilution from 2030 Notes conversions and warrants.

Risks

• Sufficiency of cash and cash equivalents to meet liquidity needs, including expenses, future revenues, capital expenditures, and capital requirements.
• Ability to obtain additional equity or debt financing and the terms of any such financing, and ability to bolster the balance sheet.
• Risks associated with indebtedness, leverage, and liquidity relating to significant debt, including ability to repay indebtedness and satisfy obligations under loan agreements and notes.
• Ability to repay or refinance the 2027 Notes, 2030 Notes, and loans under the Loan and Security Agreement.
• Ability to raise funds necessary to repurchase notes for cash or pay cash amounts due under notes, and tax liabilities from cancellation of indebtedness income.
• Impact of the exchange offer on future availability of pre-change net operating loss carryforwards and other tax attributes.
• Significant dilution to stockholders from the exchange offer and additional dilution from future equity issuances related to 2030 Notes and warrants.
• Provisions in indentures governing notes and the Loan and Security Agreement delaying or preventing an otherwise beneficial takeover.
• Adverse impact on reported financial condition and results from accounting methods for the notes.
• Ability to remediate the existing material weakness in internal control over financial reporting and maintain effective internal control and disclosure controls.
• Further decrease in demand in the plant-based meat category, exacerbated by macroeconomic trends like high inflation and geopolitical instability.
• Market price fluctuations of common stock reflecting market and trading dynamics unrelated to underlying business performance.
• Impact of general economic conditions (inflation, recession, tariffs, trade wars) on consumers, customers, suppliers, and vendors.
• Risks and uncertainties related to identifying and executing cost-reduction initiatives, cost structure improvements, and achieving profitability objectives.
• Ability to successfully execute the Global Operations Review, including exit or discontinuation of product lines, and potential non-cash charges.
• Matters relating to the Campus Headquarters, including meeting lease obligations, cost overruns, delays, and ability to surrender, sublease, or transfer excess space.
• Reduced consumer confidence and changes in consumer spending, particularly due to premium pricing of plant-based meat relative to animal protein.
• Inability to properly manage and sell inventory in a timely manner, leading to liquidation sales, write-downs, or write-offs.
• Impairment charges due to future changes in estimates, failure to achieve forecasted results, or market conditions.
• Ability to accurately predict consumer taste preferences, trends, and demand, and successfully innovate and commercialize new products.
• Effects of competitive activity from market competitors and new market entrants.
• Ability to protect the brand against misinformation, perceived quality/health issues, and negative publicity.
• Disruption to and uncertainty in the domestic and international supply chain, including labor shortages, shipping delays, and cyber incidents.
• Ability to streamline operations and improve cost efficiencies, potentially leading to business contraction and further downsizing.
• Impact of uncertainty from doing business internationally, including the suspension of China operations.
• Volatility of or inability to access capital markets due to macroeconomic factors or geopolitical tensions.
• Changes in the retail and foodservice landscapes, including distribution, market share, and sales velocity.
• Outcomes and costs related to legal or administrative proceedings.
• Foreign currency exchange rate fluctuations.
• Ability to effectively optimize manufacturing and production capacity, and real estate footprint, including risks of underutilization fees and termination fees.
• Failure to obtain stockholder approval for proposals related to 2030 Notes and authorized shares, potentially requiring cash settlement of obligations.
• Any changes in, or changes in the interpretation of, applicable laws, regulations or policies of the FDA or USDA, state regulators or similar foreign regulatory authorities that relate to the use of the word meat or other similar words in connection with plant-based meat products could adversely affect our business, prospects, results of operations or financial condition.

Future Outlook

The company expects to continue operating at a loss for the foreseeable future, despite implementing a business plan focused on achieving sustainable, profitable operations. It intends to further reduce operating expenses, utilize inventory management to reduce working capital, and invest in capital projects to reduce production costs. The company anticipates raising additional capital through equity and/or debt securities to fund operations and repay indebtedness, acknowledging potential significant dilution to existing stockholders. The ability to achieve profitability and financial performance objectives is dependent on various assumptions and uncertainties, including demand in the plant-based meat category, ability to raise capital, manage costs, and monetize inventory.

Management Comments

• Our operating environment continues to be affected by uncertainty related to macroeconomic issues, including ongoing, further weakened demand in the plant-based meat category and for our products, inflation, higher interest rates, current and proposed future tariffs and related trade wars, increased uncertainty surrounding international trade policy and regulations, including through the implementation of retaliatory tariffs or related counter-measures and the negative effects of anti-American sentiment, and potential recessionary concerns, among other things, all of which have had and could continue to have unforeseen impacts on our actual realized results.
• We have generated losses since inception. Net loss in the three months ended September 27, 2025 and September 28, 2024 was $110.7 million and $26.6 million, respectively, and net loss in the nine months ended September 27, 2025 and September 28, 2024 was $192.8 million and $115.4 million, respectively, as weak demand in the category and for our products, changes in product sales mix and distribution losses in certain channels, among other things, resulted in declines in our net revenues that we were unable to offset with commensurate cost reductions.
• We may not be able to fully realize the cost savings and benefits initially anticipated from our cost-reduction initiatives and Global Operations Review, and the realized costs may be greater than expected.
• Management has concluded that inadequate technical resources are currently in place to effectively identify and determine the proper accounting for non-recurring complex transactions such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.

Industry Context

The plant-based meat category continues to experience prolonged weak demand, exacerbated by macroeconomic headwinds such as high inflation and higher interest rates. Consumers are shifting purchases to lower-priced or conventional animal-based protein offerings, which generally have lower retail prices. This trend, coupled with increased competitive activity and negative perceptions about the health attributes of plant-based meats, is significantly impacting the industry. Beyond Meat's performance reflects these broader industry challenges, with declining revenues and increased losses, indicating a difficult operating environment for plant-based protein companies.

Comparison to Industry Standards

• NA

Management Changes

Corporate Governance

Legal Proceedings

• Aliments BVeggie, Inc. filed a lawsuit claiming CAD 129.8 million in damages; the company's motion to refer the dispute to arbitration in California was granted, but BVeggie appealed, and the appeals were heard on October 30, 2025, and are under advisement. A separate litigation to void a $5.1 million machinery purchase agreement is also suspended.
• The class action lawsuit Saskatchewan Healthcare Employees Pension Plan v. Beyond Meat, Inc. et al., alleging false and misleading statements regarding manufacturing capabilities, was dismissed with prejudice on February 27, 2025.
• Several stockholder derivative actions (Gervat, Brink, Moore, Gilardy) alleging similar facts to the SHEPP action were all dismissed without prejudice by May 8, 2025.
• A Section 220 DGCL litigation (Brown v. Beyond Meat) seeking books and records was dismissed without prejudice on April 24, 2025.
• Consumer class actions regarding protein claims were settled for $7.5 million, with final court approval on March 24, 2025. The company paid $250,000 in August 2024 and the final $7.25 million into escrow by May 14, 2025.
• In the Interbev case in France, the Commercial Court of Paris ruled on February 27, 2025, that the company can use 'meaty names' but not 'meat' to describe products, must remove the caped steer logo within 18 months, and engaged in illegal comparative advertising. The company was ordered to pay EUR 1 for financial damage, EUR 50,000 for moral damage, and EUR 15,000 for legal costs. The company appealed this judgment on September 15, 2025.
• The EUIPO Board of Appeal upheld a decision that the Caped Steer logo trademark is invalid for meat/dairy substitute goods but valid for other plant-based goods; the company decided against further appeal. A separate proceeding regarding misleading use was rejected.
• The French High Administrative Court annulled the Contested Decree and New Decree prohibiting meat names for plant-based foods on January 28, 2025, and Beyond Meat was reimbursed EUR 3,000 for legal costs.
• In arbitration with a former co-manufacturer claiming $73.0 million in damages, an interim award on September 15, 2025, found the company had a valid basis to terminate the agreement. The manufacturer's request to re-open the hearing was denied on October 20, 2025.
• In the trademark infringement litigation Sonate v. Dunkin Brands Group, Inc. and Beyond Meat, Inc., Dunkin settled, and the case continues against Beyond Meat. A jury trial commenced on November 10, 2025, after motions for summary judgment were largely denied for both parties on liability issues.

Related Party Transactions

• The company recognized its share of net loss in The Planet Partnership, LLC (TPP), a joint venture with PepsiCo, Inc., in the amount of $7,000 for Q3 2025 and $77,000 for YTD Q3 2025. The company had contributed $27.6 million to TPP as of September 27, 2025.

Stakeholder Impact

• **Shareholders**: Significant dilution from the debt exchange and ATM program, increased net losses, and a material weakness in internal controls are likely to negatively impact shareholder value and confidence. The stock price has already experienced high volatility and a 52-week low.
• **Employees**: Ongoing workforce reductions (November 2023, February 2025, August 2025 RIFs) and the suspension of China operations indicate job losses and potential adverse effects on employee morale and retention.
• **Customers**: Reduced points of distribution and weak category demand suggest a declining customer base or reduced purchasing frequency. Changes in pricing strategy and product mix may impact customer loyalty and accessibility.
• **Creditors**: The debt exchange offer and new term loan facility have altered the company's debt structure, with new 2030 Notes being secured second-lien obligations. The Loan and Security Agreement includes covenants that restrict cash interest payments and debt repayment, impacting creditor flexibility.
• **Suppliers**: The pea protein supply agreement with Roquette Frères has been revised and extended, indicating continued business, but overall declining demand could impact future supplier relationships and volumes.

Next Steps

• Continue to implement the Global Operations Review, narrowing commercial focus and accelerating activities that prioritize gross margin expansion and cash generation.
• Develop and implement a remediation plan to address the identified material weakness in internal control over financial reporting, including allocating additional resources, providing targeted training, and engaging external accounting advisors.
• Hold a special meeting of stockholders on November 19, 2025, to approve an increase in authorized common stock and the issuance of shares under the 2030 Notes and Restated Plan.
• Continue to use proceeds from Delayed Draw Term Loans for general corporate purposes.
• Monitor and manage the pea protein purchase commitment with Roquette Frères, with $5.4 million remaining for 2025.
• Proceed with the jury trial in the Sonate v. Beyond Meat trademark infringement case, which commenced on November 10, 2025.
• File the first full appeal brief in the Interbev case by February 16, 2026, following the appeal against the Commercial Court of Paris judgment.
• Continue to assess and potentially implement further measures to streamline operations and improve cost efficiencies, which could result in further downsizing and exiting certain operations.

Key Dates

Recommendation

Beyond Meat's Q3 2025 results and subsequent events paint a dire picture. The company reported a substantial decline in revenues, a significant increase in net loss, and a massive impairment charge, reflecting deep-seated issues with demand in the plant-based meat category and operational inefficiencies. While the debt exchange offer and ATM capital raise provide some short-term liquidity, they come at the cost of severe shareholder dilution and increased debt obligations with restrictive covenants. The identified material weakness in internal controls further undermines investor confidence. The ongoing workforce reductions and suspension of China operations indicate a contraction of the business. Given the persistent weak demand, deteriorating financial performance, and significant dilution, the stock faces substantial downside risk, making it a strong sell for investors.

Keywords

Plant-based meat, SEC filing, 10-Q, Financial results, Net loss, Revenue decline, Impairment charge, Debt exchange, Convertible notes, Capital raise, Workforce reduction, Global operations review, Lease modification, Sublease, Internal controls, Material weakness, Litigation, Food industry, BYND